CHSI Related Analyst Ratings
-
Argus Downgrades Catalyst Health Solutions (CHSI) to Hold
-
BMO Capital Downgrades Catalyst Health Solutions (CHSI) to Market Perform
-
UBS on Healthcare Distribution - PBMs: Implications from SXCI/CHSI Deal
-
Noble Financial Downgrades Catalyst Health Solutions (CHSI) to Sell
-
Maxim Group Downgrades Catalyst Health Solutions (CHSI) to Hold
-
Jefferies Boosts Price Target on Catalyst Health Solutions (CHSI) to $100 On Deal
-
Maxim Group Upgrades Catalyst Health Solutions (CHSI) to Buy
-
Citi Boosts Price Target on Catalyst Health Solutions (CHSI) to $73
-
Noble Financial Cuts Catalyst Health Solutions (CHSI) to Hold
-
Stifel Nicolaus Starts Catalyst Health Solutions (CHSI) at Hold
-
Dougherty Sees Recent Acquisitions as Strong Positives for Catalyst Health Solutions (CHSI)
-
Oppenheimer Starts Catalyst Health Solutions (CHSI) at Perform
-
Goldman Sachs Starts Catalyst Health Solutions (CHSI) at Neutral
-
Morgan Stanley Starts Catalyst Health Solutions (CHSI) at Equalweight
-
FBR Capital Maintains an 'Outperform' on Catalyst Health Solutions (CHSI); New Guidance Shows Typical Conservative Stance
-
Barclays Maintains an 'Overweight' on Catalyst Health Solutions (CHSI); Updated Guidance About as Expected: Constructive View Maintained
-
Barclays Maintains an 'Overweight' on Catalyst Health Solutions (CHSI); What We Are Expecting
-
Citi Starts Catalyst Health Solutions (CHSI) at Buy
-
BMO Capital Upgrades Catalyst Health Solutions (CHSI) to Outperform
-
Catalyst Health (CHSI) Shares Down as William Blair Cuts to Market Perform
-
FBR Capital Maintains an 'Outperform' on Catalyst Health Solutions (CHSI); Executing on Its Game Plan
-
FBR Capital on Healthcare Services 1Q11 Earnings Preview
-
FBR Capital Maintains an 'Outperform' on Catalyst Health Solutions (CHSI); Despite Expectations for a Weak 1Q, Sticking With Outperform
-
BMO Capital Downgrades Catalyst Health Solutions (CHSI) to Market Perform
-
Canaccord Genuity Morning Coffee on Walgreen (WAG) and Catalyst Health (CHSI): Breaking Up...Not So Hard To Do
-
Barclays Maintains an 'Overweight' on Catalyst Health Solutions (CHSI); 'Hurry up and Wait': CVS Comments Lead to Update on Maryland PBM Contract Protest
-
UBS Maintains a 'Buy' on Cardinal Health (CAH); Still The Cheapest Stock In Our Universe
-
Maxim Group Starts Catalyst Health Solutions (CHSI) at Hold
-
Raymond James Downgrades Catalyst Health Solutions (CHSI) to Market Perform
-
Barclays Maintains an 'Overweight' on Catalyst Health Solutions (CHSI); Model Update to Reflect Adjusted EPS
-
FBR Capital Maintains an 'Outperform' on Catalyst Health Solutions (CHSI); Joining In on the PBM Party; Outlook Is for Good Times Ahead
-
BB&T Upgrades Catalyst Health (CHSI) to Buy, Sets $42 Price Target
-
FBR Capital Launching Coverage of Pharmacy Benefit Management Services: Trends Favor the Prepared
-
JMP Securities Initiates Coverage on Catalyst Health Solutions (CHSI) with a Market Outperform
-
Barclays Upgrades Catalyst Health Solutions (CHSI) to Overweight
-
Noble Financial Upgrades Catalyst Health Solutions (CHSI) to Buy
-
Barclays Downgrades Catalyst Health Solutions (CHSI) to Equalweight
-
BMO Capital Upgrades Catalyst Health Solutions (CHSI) to Outperform
-
BMO Capital Downgrades Catalyst Health Solutions (CHSI) to Market Perform
-
ThinkEquity Downgrades Catalyst Health Solutions (CHSI) to Source of Funds
-
BB&T Capital Downgrades Catalyst Health Solutions (CHSI) to Hold
-
BB&T Upgrades Catalyst Health (CHSI) to Buy
Back to CHSI Stock Lookup
